Biodexa Pharmaceuticals (BDRX) Goodwill (2017 - 2022)

Biodexa Pharmaceuticals (BDRX) has 4 years of Goodwill data on file, last reported at $1.3 million in Q2 2022.

• For the quarter ending Q2 2022, Goodwill changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2022 stood at $1.3 million (changed N/A YoY), and the FY2019 full-year result was $2.9 million, down 4.4% from the prior year.
• Goodwill retreated to $1.3 million in Q2 2022, from $3.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $9.1 million in Q2 2018 to a low of $1.3 million in Q2 2022.
• A 3-year average of $4.1 million and a median of $3.0 million in 2019 frame the typical range for Goodwill.
• Across the five-year window, Goodwill tumbled 83.36% in 2018 and declined 0.08% in 2019, its largest moves.
• Tracing BDRX's Goodwill over 3 years: stood at $3.0 million in 2018, then fell by 0.08% to $3.0 million in 2019, then tumbled by 57.71% to $1.3 million in 2022.
• Business Quant data shows BDRX's Goodwill at $1.3 million in Q2 2022, $3.0 million in Q4 2019, and $3.0 million in Q4 2018.